Home / Drug shortages / Valproate Sodium Injection

Valproate Sodium Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Valproate Sodium Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 12/30/2020.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9785-10
Dosage Form
Injection
Presentation
Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10)
Initial Posting
12/30/2020
Revised Date

FDA data resources